These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12849923)

  • 21. [Steps toward the primary prevention of type II diabetes mellitus. Various epidemiological considerations].
    Flórez H
    Invest Clin; 1997 Mar; 38(1):39-52. PubMed ID: 9235072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucose intolerance (diabetes and IGT) in a selected South Indian population with special reference to family history, obesity and lifestyle factors--the Chennai Urban Population Study (CUPS 14).
    Mohan V; Shanthirani CS; Deepa R
    J Assoc Physicians India; 2003 Aug; 51():771-7. PubMed ID: 14651136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impaired glucose regulation in adults in Jamaica: who should have the oral glucose tolerance test?
    Sargeant LA; Boyne MS; Bennett FI; Forrester TE; Cooper RS; Wilks RJ
    Rev Panam Salud Publica; 2004 Jul; 16(1):35-42. PubMed ID: 15333264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screen detected subjects with type 2 diabetes and impaired glucose tolerance have more adverse cardiovascular risk than subjects with impaired fasting glucose especially when they are obese: the ADDITION Netherlands study.
    Janssen PG; Gorter KJ; Stolk RP; Rutten GE
    Prim Care Diabetes; 2007 Jun; 1(2):69-74. PubMed ID: 18632022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identical anthropometric characteristics of impaired fasting glucose combined with impaired glucose tolerance and newly diagnosed type 2 diabetes: anthropometric indicators to predict hyperglycaemia in a community-based prospective cohort study in southwest China.
    Zhang F; Wan Q; Cao H; Tang L; Li D; Lü Q; Yan Z; Li J; Yang Q; Zhang Y; Tong N
    BMJ Open; 2018 May; 8(5):e019735. PubMed ID: 29743321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of type 2 diabetes mellitus and impaired glucose tolerance in the Kashmir Valley of the Indian subcontinent.
    Zargar AH; Khan AK; Masoodi SR; Laway BA; Wani AI; Bashir MI; Dar FA
    Diabetes Res Clin Pract; 2000 Feb; 47(2):135-46. PubMed ID: 10670914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Fasting or post-challenge blood glucose values for detection of glucose intolerance in screening for metabolic syndrome?].
    Jermendy G; Hidvégi T; Hetyési K; Bíró L
    Orv Hetil; 2002 Sep; 143(39):2247-52. PubMed ID: 12418378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fasting plasma glucose as initial screening for diabetes and prediabetes in irish adults: The Diabetes Mellitus and Vascular health initiative (DMVhi).
    Sinnott M; Kinsley BT; Jackson AD; Walsh C; O'Grady T; Nolan JJ; Gaffney P; Boran G; Kelleher C; Carr B
    PLoS One; 2015; 10(4):e0122704. PubMed ID: 25874867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diabetes screening after gestational diabetes mellitus: poor performance of fasting plasma glucose.
    Cypryk K; Czupryniak L; Wilczyński J; Lewiński A
    Acta Diabetol; 2004 Mar; 41(1):5-8. PubMed ID: 15057547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lifestyle intervention in individuals with normal versus impaired glucose tolerance.
    Schäfer S; Kantartzis K; Machann J; Venter C; Niess A; Schick F; Machicao F; Häring HU; Fritsche A; Stefan N
    Eur J Clin Invest; 2007 Jul; 37(7):535-43. PubMed ID: 17576204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diabetes and impaired glucose tolerance prevalences in Turkish patients with impaired fasting glucose.
    Tutuncuoğlu P; Saraç F; Saygili F; Ozgen AG; Yilmaz C; Tüzün M
    Acta Diabetol; 2008 Sep; 45(3):151-6. PubMed ID: 18496644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regional differences of undiagnosed type 2 diabetes and prediabetes prevalence are not explained by known risk factors.
    Tamayo T; Schipf S; Meisinger C; Schunk M; Maier W; Herder C; Roden M; Nauck M; Peters A; Völzke H; Rathmann W
    PLoS One; 2014; 9(11):e113154. PubMed ID: 25402347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of The World Health Organization (WHO) two-step strategy and OGTT for diabetes mellitus screening.
    Adam JM; Tarigan NP
    Acta Med Indones; 2004; 36(1):3-7. PubMed ID: 15931695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High prevalence of neuropathy in patients with impaired 60-minute oral glucose tolerance test but normal fasting and 120-minute glucose levels.
    Sahin M; Karatas M; Sahin M; Ertugrul D; Kulaksizoğlu M; Dogruk A; Gokcel A; Tutuncu NB; Guvener ND; Kutlu M
    Minerva Endocrinol; 2008 Dec; 33(4):289-96. PubMed ID: 18923366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening for impaired glucose tolerance in obese children and adolescents: a validation and implementation study.
    Morandi A; Maschio M; Marigliano M; Miraglia Del Giudice E; Moro B; Peverelli P; Maffeis C
    Pediatr Obes; 2014 Feb; 9(1):17-25. PubMed ID: 23296488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Men with impaired glucose tolerance have lower self-rated health than men with impaired fasting glucose.
    Diurlin S; Eriksson MCM; Daka B; Lindblad U; Hellgren M
    Prim Care Diabetes; 2020 Feb; 14(1):40-46. PubMed ID: 31204262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of chronic kidney disease in young adults with impaired glucose tolerance/impaired fasting glucose: a retrospective cohort study using electronic primary care records.
    Jadhakhan F; Marshall T; Ryan R; Gill P
    BMC Nephrol; 2018 Feb; 19(1):42. PubMed ID: 29482513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of lifestyle interventions in reducing diabetes incidence in patients with impaired glucose tolerance: a systematic review of randomized controlled trials.
    Yoon U; Kwok LL; Magkidis A
    Metabolism; 2013 Feb; 62(2):303-14. PubMed ID: 22959500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The STOP-NIDDM Trial: an international study on the efficacy of an alpha-glucosidase inhibitor to prevent type 2 diabetes in a population with impaired glucose tolerance: rationale, design, and preliminary screening data. Study to Prevent Non-Insulin-Dependent Diabetes Mellitus.
    Chiasson JL; Gomis R; Hanefeld M; Josse RG; Karasik A; Laakso M
    Diabetes Care; 1998 Oct; 21(10):1720-5. PubMed ID: 9773737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High prevalence of abnormal glucose tolerance and metabolic disturbances in first degree relatives of NIDDM patients. A study in Catalonia, a mediterranean community.
    Costa A; Rios M; Casamitjana R; Gomis R; Conget I
    Diabetes Res Clin Pract; 1998 Sep; 41(3):191-6. PubMed ID: 9829348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.